Tebentafusp Continues to Demonstrate Benefit in Metastatic Uveal Melanoma

Retrieved on: 2024-01-04 19:11:00

Tags for this article:

Click the tags to see associated articles and topics

Tebentafusp Continues to Demonstrate Benefit in Metastatic Uveal Melanoma. View article details on HISWAI: https://www.cancernetwork.com/view/tebentafusp-continues-to-demonstrate-benefit-in-metastatic-uveal-melanoma

Excerpt

Results from a long-term analysis of the phase 3 IMCgp100-202 trial indicate that tebentafusp results in better disease control and long-lasting ...

Article found on: www.cancernetwork.com

View Original Article